Orphan drugs are medications developed specifically to treat rare diseases or conditions. In the context of cancer, these drugs target rare cancers or subtypes of more common cancers that affect a small percentage of the population. The term "orphan" is used because the pharmaceutical industry often lacks the financial incentive to develop and market these drugs under normal market conditions.
